Percutaneous transluminal coronary angioplasty is commonly called PTCA, or just angioplasty. A catheter is inserted into an artery usually into the groin and sometimes in the arm or wrist. The catheter is advanced to the heart, and a series of x-ray pictures are taken to clearly visualize the heart arteries that are narrowed. Then, a balloon-tipped catheter is advanced to the heart, and into the narrow coronary artery. Inside the artery, the balloon is inflated and deflated several times, compressing the plaque against the artery wall and widening the artery for the blood flow to improve. X-rays pictures are repeated, and if the artery has been successfully re-opened, the catheters are removed.
Market Dynamics
The increasing coronary artery disease population, rising research and development activities, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive the growth of the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market over the forecast period.
For instance, in May 2022, Medtronic, a medical device company, announced that it received approval from the U.S food and drug administration (FDA) for IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty Balloon Catheter, a drug coated balloon (DCB), indicated for the interventional treatment of peripheral artery disease (PAD) in the superficial and popliteal arteries.
Moreover, according to the data published in American Heart Association in July 2021, lower extremity peripheral artery disease (PAD) affects more than 230 million adults worldwide.
Key features of the study:
- This report provides an in-depth analysis of the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Cook Group, Medtronic Plc., Becton, Dickinson and Company, Abbott, Koninklijke Philips N.V., ENDOCOR GmbH, Cardinal Health, NIPRO, Terumo Corporation, Boston Scientific Corporation, Surmodics, Inc., Teleflex Incorporated, BIOTRONIK SE & Co. KG, Biomerics, Shockwave Medical Inc., Microport Scientific Corporation, Nordson Corporation, and S3V Vascular Technologies Pvt. Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global percutaneous transluminal coronary angioplasty (PTCA) balloon catheter market
Detailed Segmentation:
Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, By Product Type:
- Normal Balloon Catheter
- Drug Eluting Balloon Catheter
- Cutting Balloon Catheter
- Scoring Balloon Catheter
Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, By Balloon Material:
- Polyolefin copolymer (POC)
- Polyethylene (PE)
- Polyethylene terephthalate (PET)
Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, By End User:
- Hospitals
- Ambulatory Surgical Centers
Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
- Cook Group.*
- Company Overview
- Material Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- Medtronic Plc
- Becton Dickinson and Company
- Abbott
- Koninklijke Philips N.V.
- ENDOCOR GmbH
- Cardinal Health
- NIPRO
- Terumo Corporation
- Boston Scientific Corporation
- Surmodics, Inc.
- Teleflex Incorporated
- BIOTRONIK SE & Co. KG
- Biomerics
- Shockwave Medical Inc.
- Microport Scientific Corporation
- Nordson Corporation
- S3V Vascular Technologies Pvt. Ltd.
* marked represents similar segmentation in other categories in the respective section.
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Cook Group.
- Medtronic Plc
- Becton Dickinson and Company
- Abbott
- Koninklijke Philips N.V.
- ENDOCOR GmbH
- Cardinal Health
- NIPRO
- Terumo Corporation
- Boston Scientific Corporation
- Surmodics, Inc.
- Teleflex Incorporated
- BIOTRONIK SE & Co. KG
- Biomerics
- Shockwave Medical Inc.
- Microport Scientific Corporation
- Nordson Corporation
- S3V Vascular Technologies Pvt. Ltd.
